Cite

HARVARD Citation

    Burns, D. et al. (2020). Real-world Outcomes With Rituximab-based Therapy for Posttransplant Lymphoproliferative Disease Arising After Solid Organ Transplant. Transplantation. 104 (12), p. . [Online]. 
  
Back to record